TLPH | | TALPHERA, INC. | Harkey Wilmot B. | 10% Owner | Mar 15, 2024 | Option Exercise | $5.00 | 755,000 | 3,775,000 | 1,992,519 | Mar 15, 2024, 04:01 PM |
TLPH | | TALPHERA, INC. | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Mar 11, 2024 | Option Exercise | $1.12 | 1,000 | 1,115 | 162,806 | Mar 12, 2024, 06:39 PM |
TLPH | | TALPHERA, INC. | Angotti Vincent J. | CHIEF EXECUTIVE OFFICER | Mar 12, 2024 | Option Exercise | $1.12 | 8,000 | 8,995 | 170,806 | Mar 12, 2024, 06:39 PM |
TLPH | | TALPHERA, INC. | Dasu Badri N | Chief Engineering Officer | Mar 03, 2024 | Option Exercise | $1.30 | 406 | 528 | 31,414 | Mar 04, 2024, 08:57 PM |
TLPH | | TALPHERA, INC. | Palmer Pamela P | Chief Medical Officer | Mar 03, 2024 | Option Exercise | $1.30 | 450 | 585 | 59,149 | Mar 04, 2024, 08:55 PM |
TLPH | | TALPHERA, INC. | ASADORIAN RAFFI | Chief Financial Officer | Mar 03, 2024 | Option Exercise | $1.30 | 558 | 725 | 37,733 | Mar 04, 2024, 08:54 PM |
TLPH | | TALPHERA, INC. | Angotti Vincent J. | Chief Executive Officer | Mar 03, 2024 | Option Exercise | $1.30 | 1,623 | 2,110 | 161,806 | Mar 04, 2024, 08:53 PM |
TLPH | | TALPHERA, INC. | Dasu Badri N | Chief Engineering Officer | Feb 10, 2024 | Option Exercise | $1.10 | 809 | 890 | 17,962 | Feb 13, 2024, 09:46 PM |
TLPH | | TALPHERA, INC. | Dasu Badri N | Chief Engineering Officer | Feb 11, 2024 | Option Exercise | $1.10 | 809 | 890 | 17,153 | Feb 13, 2024, 09:46 PM |
TLPH | | TALPHERA, INC. | Palmer Pamela P | Chief Medical Officer | Feb 11, 2024 | Option Exercise | $1.10 | 801 | 881 | 35,344 | Feb 13, 2024, 09:44 PM |
TLPH | | TALPHERA, INC. | Palmer Pamela P | Chief Medical Officer | Feb 10, 2024 | Option Exercise | $1.10 | 801 | 881 | 36,145 | Feb 13, 2024, 09:44 PM |
TLPH | | TALPHERA, INC. | ASADORIAN RAFFI | Chief Financial Officer | Feb 10, 2024 | Option Exercise | $1.10 | 895 | 985 | 21,186 | Feb 13, 2024, 09:42 PM |
TLPH | | TALPHERA, INC. | ASADORIAN RAFFI | Chief Financial Officer | Feb 11, 2024 | Option Exercise | $1.10 | 895 | 985 | 20,291 | Feb 13, 2024, 09:42 PM |
TLPH | | TALPHERA, INC. | Angotti Vincent J. | Chief Executive Officer | Feb 10, 2024 | Option Exercise | $1.10 | 3,320 | 3,652 | 98,485 | Feb 13, 2024, 09:40 PM |
TLPH | | TALPHERA, INC. | Angotti Vincent J. | Chief Executive Officer | Feb 11, 2024 | Option Exercise | $1.10 | 3,723 | 4,095 | 94,762 | Feb 13, 2024, 09:40 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Dec 13, 2023 | Buy | $0.73 | 10,000 | 7,268 | 101,805 | Dec 14, 2023, 08:11 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Sep 11, 2023 | Buy | $0.80 | 10,000 | 7,950 | 91,805 | Sep 11, 2023, 07:13 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Aug 24, 2023 | Sale | $1.17 | 9,514 | 11,131 | 38,195 | Aug 25, 2023, 04:45 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Aug 25, 2023 | Sale | $1.09 | 7,442 | 8,104 | 30,753 | Aug 25, 2023, 04:45 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Mar 03, 2023 | Option Exercise | $1.31 | 398 | 521 | 18,771 | Mar 06, 2023, 04:45 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Mar 03, 2023 | Option Exercise | $1.31 | 570 | 747 | 43,315 | Mar 06, 2023, 04:44 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Mar 03, 2023 | Option Exercise | $1.31 | 510 | 668 | 22,081 | Mar 06, 2023, 04:42 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Mar 03, 2023 | Option Exercise | $1.31 | 1,703 | 2,231 | 63,836 | Mar 06, 2023, 04:40 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 11, 2023 | Option Exercise | $1.68 | 1,017 | 1,709 | 43,885 | Feb 14, 2023, 04:26 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 11, 2023 | Option Exercise | $1.68 | 776 | 1,304 | 19,169 | Feb 14, 2023, 04:24 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 11, 2023 | Option Exercise | $1.68 | 873 | 1,467 | 22,591 | Feb 14, 2023, 04:22 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 11, 2023 | Option Exercise | $1.68 | 3,321 | 5,579 | 65,539 | Feb 14, 2023, 04:19 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 06, 2023 | Option Exercise | $2.02 | 458 | 925 | 15,070 | Feb 08, 2023, 04:51 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 06, 2023 | Option Exercise | $2.02 | 617 | 1,246 | 17,589 | Feb 08, 2023, 04:48 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 06, 2023 | Option Exercise | $2.02 | 681 | 1,376 | 38,777 | Feb 08, 2023, 04:46 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 06, 2023 | Option Exercise | $2.02 | 1,982 | 4,004 | 49,360 | Feb 08, 2023, 04:42 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Jun 07, 2022 | Buy | $0.22 | 46,400 | 10,333 | 1,016,919 | Jun 08, 2022, 04:06 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Mar 03, 2022 | Option Exercise | $0.41 | 7,923 | 3,223 | 779,261 | Mar 04, 2022, 04:26 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Mar 03, 2022 | Option Exercise | $0.41 | 5,612 | 2,283 | 300,595 | Mar 04, 2022, 04:25 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Mar 03, 2022 | Option Exercise | $0.41 | 7,923 | 3,223 | 364,205 | Mar 04, 2022, 04:25 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Mar 03, 2022 | Option Exercise | $0.41 | 23,051 | 9,377 | 970,519 | Mar 04, 2022, 04:24 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 11, 2022 | Option Exercise | $0.40 | 7,927 | 3,182 | 777,184 | Feb 14, 2022, 04:52 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 06, 2022 | Option Exercise | $0.43 | 9,391 | 4,049 | 662,611 | Feb 07, 2022, 08:20 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 06, 2022 | Option Exercise | $0.43 | 6,830 | 2,945 | 204,322 | Feb 07, 2022, 08:19 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 06, 2022 | Option Exercise | $0.43 | 9,391 | 4,049 | 258,515 | Feb 07, 2022, 07:58 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 06, 2022 | Option Exercise | $0.43 | 27,318 | 11,780 | 616,628 | Feb 07, 2022, 07:57 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 11, 2021 | Option Exercise | $2.63 | 9,024 | 23,733 | 183,299 | Feb 12, 2021, 05:55 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 11, 2021 | Option Exercise | $2.63 | 6,775 | 17,818 | 144,757 | Feb 12, 2021, 05:53 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 11, 2021 | Option Exercise | $2.63 | 8,915 | 23,446 | 593,098 | Feb 12, 2021, 05:51 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 11, 2021 | Option Exercise | $2.63 | 23,052 | 60,627 | 427,887 | Feb 12, 2021, 05:50 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 06, 2021 | Option Exercise | $2.59 | 9,414 | 24,382 | 192,323 | Feb 09, 2021, 04:33 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 06, 2021 | Option Exercise | $2.59 | 6,846 | 17,731 | 151,532 | Feb 09, 2021, 04:31 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 06, 2021 | Option Exercise | $2.59 | 9,414 | 24,382 | 602,013 | Feb 09, 2021, 04:30 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 06, 2021 | Option Exercise | $2.59 | 25,059 | 64,903 | 450,939 | Feb 09, 2021, 04:29 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ADAMS ADRIAN | Director | Jun 15, 2020 | Buy | $1.29 | 100,000 | 128,900 | 178,750 | Jun 15, 2020, 06:39 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ADAMS ADRIAN | Director | Jun 15, 2020 | Buy | $1.29 | 100,000 | 128,900 | 178,750 | Jun 15, 2020, 06:01 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Jun 15, 2020 | Buy | $1.33 | 7,547 | 10,035 | 468,757 | Jun 15, 2020, 06:00 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 11, 2020 | Option Exercise | $1.71 | 5,613 | 9,598 | 157,654 | Feb 13, 2020, 04:15 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Feb 11, 2020 | Option Exercise | $1.71 | 5,613 | 9,598 | 127,769 | Feb 13, 2020, 04:14 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 11, 2020 | Option Exercise | $1.71 | 7,924 | 13,550 | 604,983 | Feb 13, 2020, 04:14 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 11, 2020 | Option Exercise | $1.71 | 7,924 | 13,550 | 188,765 | Feb 13, 2020, 04:12 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 11, 2020 | Option Exercise | $1.71 | 23,052 | 39,419 | 452,892 | Feb 13, 2020, 04:12 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Nov 12, 2019 | Buy | $1.78 | 25,000 | 44,575 | 243,750 | Nov 12, 2019, 04:22 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Nov 11, 2019 | Buy | $1.79 | 8,379 | 14,973 | 275,944 | Nov 12, 2019, 06:07 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Aug 23, 2019 | Buy | $2.20 | 10,000 | 21,956 | 213,750 | Aug 26, 2019, 04:52 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Aug 26, 2019 | Buy | $2.17 | 5,000 | 10,849 | 218,750 | Aug 26, 2019, 04:52 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Jun 05, 2019 | Buy | $2.31 | 5,000 | 11,550 | 262,884 | Jun 06, 2019, 06:02 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Mar 12, 2019 | Buy | $2.99 | 19,000 | 56,890 | 200,000 | Mar 12, 2019, 02:15 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Feb 28, 2019 | Buy | $2.81 | 3,647 | 10,248 | 124,397 | Mar 04, 2019, 04:28 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Feb 28, 2019 | Buy | $2.81 | 9,206 | 25,869 | 113,267 | Mar 04, 2019, 04:26 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Feb 28, 2019 | Buy | $2.81 | 3,234 | 9,088 | 257,884 | Mar 04, 2019, 04:25 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Feb 28, 2019 | Buy | $2.81 | 3,682 | 10,346 | 78,053 | Mar 04, 2019, 04:24 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Feb 28, 2019 | Buy | $2.81 | 840 | 2,360 | 541,724 | Mar 04, 2019, 12:00 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Dec 14, 2018 | Buy | $2.78 | 3,610 | 10,024 | 54,650 | Dec 17, 2018, 12:05 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Dec 14, 2018 | Buy | $2.78 | 5,000 | 13,883 | 52,000 | Dec 17, 2018, 12:04 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Dec 12, 2018 | Buy | $2.99 | 10,000 | 29,890 | 51,040 | Dec 12, 2018, 07:31 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Nov 19, 2018 | Buy | $3.07 | 16,000 | 49,120 | 472,134 | Nov 19, 2018, 06:13 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Nov 15, 2018 | Buy | $2.82 | 20,700 | 58,376 | 181,000 | Nov 15, 2018, 06:35 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Nov 13, 2018 | Buy | $3.13 | 5,000 | 15,646 | 47,000 | Nov 13, 2018, 01:53 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Nov 02, 2018 | Option Exercise | $3.61 | 10,000 | 36,125 | 34,795 | Nov 05, 2018, 05:29 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Oct 15, 2018 | Sale | $5.00 | 5,216 | 26,080 | 29,795 | Oct 16, 2018, 04:30 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Oct 15, 2018 | Sale | $5.00 | 28,351 | 141,755 | 54,061 | Oct 16, 2018, 04:29 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Sep 24, 2018 | Sale | $4.50 | 6,953 | 31,289 | 35,011 | Sep 26, 2018, 05:54 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Aug 31, 2018 | Option Exercise | $1.49 | 8,022 | 11,953 | 82,412 | Sep 05, 2018, 06:08 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Aug 31, 2018 | Option Exercise | $1.49 | 10,000 | 14,900 | 42,000 | Sep 05, 2018, 06:06 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Aug 31, 2018 | Option Exercise | $1.49 | 6,040 | 9,000 | 41,040 | Sep 05, 2018, 06:06 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Aug 31, 2018 | Option Exercise | $1.49 | 6,876 | 10,245 | 24,371 | Sep 05, 2018, 06:06 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Aug 07, 2018 | Buy | $2.84 | 5,300 | 15,063 | 160,300 | Aug 08, 2018, 04:36 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Aug 07, 2018 | Buy | $2.89 | 10,000 | 28,950 | 35,000 | Aug 07, 2018, 04:08 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Aug 06, 2018 | Buy | $2.75 | 37,000 | 101,750 | 456,134 | Aug 06, 2018, 05:38 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Aug 06, 2018 | Buy | $2.74 | 5,000 | 13,725 | 32,000 | Aug 06, 2018, 05:23 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Jun 01, 2018 | Buy | $3.30 | 300 | 990 | 150,300 | Jun 05, 2018, 05:52 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Jun 05, 2018 | Buy | $3.35 | 4,700 | 15,745 | 155,000 | Jun 05, 2018, 05:52 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | May 25, 2018 | Buy | $3.18 | 5,000 | 15,922 | 27,000 | May 29, 2018, 06:52 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Nov 14, 2017 | Buy | $1.90 | 30,000 | 56,970 | 150,000 | Nov 15, 2017, 07:01 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Nov 13, 2017 | Buy | $1.94 | 5,000 | 9,711 | 12,000 | Nov 14, 2017, 07:01 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | Dasu Badri N | Chief Engineering Officer | Oct 19, 2017 | Option Exercise | $1.20 | 37,500 | 45,000 | 74,390 | Oct 20, 2017, 07:01 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Oct 02, 2017 | Sale | $5.29 | 10,161 | 53,752 | 41,964 | Oct 03, 2017, 12:00 AM |
ACRX | | ACELRX PHARMACEUTICALS INC | ASADORIAN RAFFI | Chief Financial Officer | Sep 11, 2017 | Buy | $3.24 | 7,000 | 22,705 | 7,000 | Sep 11, 2017, 05:36 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Angotti Vincent J. | Chief Executive Officer | Aug 24, 2017 | Buy | $3.00 | 15,000 | 45,000 | 15,000 | Aug 24, 2017, 06:14 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Aug 22, 2017 | Buy | $2.90 | 200 | 580 | 115,200 | Aug 24, 2017, 05:54 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDWARDS MARK G | Director | Aug 24, 2017 | Buy | $3.03 | 4,800 | 14,520 | 120,000 | Aug 24, 2017, 05:54 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Palmer Pamela P | Chief Medical Officer | Aug 22, 2017 | Buy | $2.95 | 10,000 | 29,487 | 415,801 | Aug 22, 2017, 05:19 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | EDELMAN JOSEPH | 10% Owner | Jun 19, 2017 | Sale | $2.40 | 875,000 | 2,100,000 | 4,533,728 | Jun 21, 2017, 04:45 PM |
ACRX | | ACELRX PHARMACEUTICALS INC | Hamel Lawrence G | Chief Development Officer | Apr 10, 2017 | Option Exercise | $1.20 | 9,122 | 10,946 | 73,475 | Apr 11, 2017, 05:29 PM |